Bill price target lowered to $95 from $100 at KeyBanc

KeyBanc analyst Josh Beck lowered the firm’s price target on Bill to $95 from $100 and keeps an Overweight rating on the shares ahead of the quarterly earnings report on May 4. Three data sources have indicated sequential trends were down mid single to low double digits in Q1, the analyst tells investors in a research note.